Observational, Cross-Sectional Post-Authorisation Safety Study to Assess Healthcare Provider Awareness of Risks Related to Sofosbuvir and Ledipasvir/Sofosbuvir (EU HVN SOF Survey Study)

First published 08/09/2016

Last updated 31/03/2024

EU PAS number:

EUPAS15103

Study

Finalised

Documents

Study protocol

Initial protocol

1.2-Prot GS-EU-337-2030 FINAL SIGNED

English (908.64 KB - PDF)View document

Study results

GS-EU-337-2030+ABSTRACT+Clinical+Study+Report

English (102.32 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs